In contrast, to our knowledge the role of the alternative RelB NF-κB subunit in cancer cell metabolism has not yet been reported, and whether it may impact on DLBCL OxPhos status for survival remains an unanswered question. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.